DSM705 hydrochloride,99.56%

产品编号:Bellancom-132171A| 分子式:C19H20ClF3N6O| 分子量:440.85

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-132171A
3700.00 杭州 北京(现货)
Bellancom-132171A
5900.00 杭州 北京(现货)
Bellancom-132171A
11800.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

DSM705 hydrochloride

产品介绍 DSM705 hydrochloride,一种具有口服活性的抗疟化合物,是基于吡咯的二氢乳清酸脱氢酶 (DHODH) 抑制剂。DSM705 hydrochloride 对 Plasmodium DHODH 和 Plasmodium 寄生虫表现出纳摩尔级效力 (抑制 P. falciparumP. vivax DHODH 的 IC50 分别为 95 nM 和 52 nM),对哺乳动物 DHODH 没有抑制作用。
生物活性

DSM705 hydrochloride, an orally active antimalarial compound, is a pyrrole-based Dihydroorotate Dehydrogenase (DHODH) inhibitor. DSM705 hydrochloride exhibits nanomolar potency against Plasmodium DHODH and Plasmodium parasites (IC50=95, 52 nM for P. falciparum and P. vivax DHODH, respectively), with no inhibition of mammalian DHODHs.

体外研究

DSM705 hydrochloride shows inhibitory activity against P. falciparum DHODH (PfDHODH, IC50=95 nM), P. vivax DHODH (PvDHODH, IC50=52 nM) and Pf3D7 cells (EC50=12 nM), with no inhibition of the human enzyme.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

DSM705 (3-200 mg/kg; p.o. twice a day for 6 days) hydrochloride provides the maximum rate of parasite killing at the dose of 50 mg/kg and fully suppresses parasitemia by days 7-8.
DSM705 (2.6 and 24 mg/kg; a single p.o.) hydrochloride exhibits high oral bioavailability (74%, 70%), apparent t1/2 (3.4, 4.5 h) and Cmax (2.6, 20 μM) in Swiss outbred mice.
DSM705 (2.3 mg/kg; a single i.v.) hydrochloride exhibits plasma clearance (CL=2.8 mL/min/kg) and Vss (1.3 L/kg) in mice.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SCID mice were inoculated with parasites
Dosage: 3, 10, 20, 50, 100, 200 mg/kg
Administration: P.o. twice a day for 6 days
Result: Killed parasite in a dose dependent manner and fully suppressed parasitemia by days 7-8.
Animal Model: Swiss Outbred Mice
Dosage: 2.6 and 24 mg/kg for p.o.; 2.3 mg/kg for i.v. (Pharmacokinetic Analysis)
Administration: A single p.o. and i.v.
Result: P.o.: F=74/70%, t1/2=3.4/4.5 h, Cmax=2.6/20 μM.
I.v.: CL=2.8 mL/min/kg, Vss=1.3 L/kg.
体内研究

DSM705 (3-200 mg/kg; p.o. twice a day for 6 days) hydrochloride provides the maximum rate of parasite killing at the dose of 50 mg/kg and fully suppresses parasitemia by days 7-8.
DSM705 (2.6 and 24 mg/kg; a single p.o.) hydrochloride exhibits high oral bioavailability (74%, 70%), apparent t1/2 (3.4, 4.5 h) and Cmax (2.6, 20 μM) in Swiss outbred mice.
DSM705 (2.3 mg/kg; a single i.v.) hydrochloride exhibits plasma clearance (CL=2.8 mL/min/kg) and Vss (1.3 L/kg) in mice.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SCID mice were inoculated with parasites
Dosage: 3, 10, 20, 50, 100, 200 mg/kg
Administration: P.o. twice a day for 6 days
Result: Killed parasite in a dose dependent manner and fully suppressed parasitemia by days 7-8.
Animal Model: Swiss Outbred Mice
Dosage: 2.6 and 24 mg/kg for p.o.; 2.3 mg/kg for i.v. (Pharmacokinetic Analysis)
Administration: A single p.o. and i.v.
Result: P.o.: F=74/70%, t1/2=3.4/4.5 h, Cmax=2.6/20 μM.
I.v.: CL=2.8 mL/min/kg, Vss=1.3 L/kg.
性状Solid
溶解性数据
In Vitro: 

DMSO : 100 mg/mL (226.83 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.2683 mL 11.3417 mL 22.6835 mL
5 mM 0.4537 mL 2.2683 mL 4.5367 mL
10 mM 0.2268 mL 1.1342 mL 2.2683 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (5.67 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (5.67 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液
  • 2.

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (5.67 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (5.67 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
  • 3.

    请依序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 2.5 mg/mL (5.67 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (5.67 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在 西域 网站选购。
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服